All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MDS Alliance.
The MDS Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
Therapy-related myeloid neoplasms
Therapy-related myeloid neoplasms
The 2016 World Health Organization (WHO) classification considers those myeloid neoplasms which are diagnosed after prolonged exposure to chemotherapy and/or radiation therapy for another malignant disease as “therapy related”. These patients may develop therapy-related acute myeloid leukemia (t-AML), myelodysplastic syndromes (t-MDS), or MDS/myeloproliferative neoplasms (t-MDS/MPN).
|||